Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease
Open Access
- 1 January 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 35 (Supplement) , i1-i2
Abstract
The kidneys play an important role in maintaining glucose homoeostasis through the production of glucose via gluconeogenesis. They not only filter and reabsorb plasma glucose, but also use glucose as a metabolic fuel. These physiologic processes have been studied for a long time but have become an area of renewed and intense research interest in recent years as a result of the benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in reducing cardiovascular outcomes and delaying the progression of chronic kidney disease (CKD) in patients with type 2 diabetes.Keywords
This publication has 18 references indexed in Scilit:
- The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 DiabetesDiabetes Care, 2019
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trialThe Lancet Diabetes & Endocrinology, 2019
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2019
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsThe Lancet Diabetes & Endocrinology, 2018
- Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyAmerican Journal of Physiology-Renal Physiology, 2018
- Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesNew England Journal of Medicine, 2016
- Canagliflozin: Effects in overweight and obese subjects without diabetes mellitusObesity, 2013
- Biology of Human Sodium Glucose TransportersPhysiological Reviews, 2011
- T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.Diabetes, 1999
- Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitusAmerican Journal of Physiology-Renal Physiology, 1991